The following drugs face patent expirations in June 2006

Applicant :: TRADENAME :: generic name

Bristol Myers Squibb :: SINEMET CR :: carbidopa; levodopa
Purdue Pharma Lp :: SPECTRACEF :: cefditoren pivoxil
Merck :: PROPECIA :: finasteride
Merck :: PROSCAR :: finasteride
Galderma Labs Lp :: METROGEL :: metronidazole
3m :: METROGEL-VAGINAL :: metronidazole
Procter And Gamble :: MACROBID :: nitrofurantoin; nitrofurantoin, macrocrystalline
Boehringer Ingelheim :: MIRAPEX :: pramipexole dihydrochloride
Pfizer :: ZOLOFT :: sertraline hydrochloride
Merck :: ZOCOR :: simvastatin
Gd Searle Llc :: COVERA-HS :: verapamil hydrochloride

This list does not discriminate between dominant and non-dominant patents. Listed drugs above may be protected by additional patents and other regulatory protections.

For more details, visit DrugPatentWatch at http://www.DrugPatentWatch.com

To subscribe to the free Patent Expiration Bulletin, visit http://www.DrugPatentWatch.com/newsletter

Disclaimer:
All trademarks and applicant names are the property of their respective owners or licensors. Drug patent expiration data is presented "as is." Use of this information is at your own risk. No warranty is expressed or implied. There is no warranty that the drug patent expriation information is error free.

---
ABOUT DrugPatentWatch ( http://www.DrugPatentWatch.com )

DrugPatentWatch provides information on drug patent expirations. Complete details are provided for all FDA-approved small molecule drugs. Sales information is available for top-selling drugs. This value-added information supports the critical business functions of patent agents and attorneys, pharmaceutical companies, wholesalers, healthcare payers, and investors.